Regulation of Foxp3 Function
Regulation of Foxp3 Function
批准号:
7749570
负责人:
ANDREW D WELLS
金额:
$36.64万
依托单位国家:
美国
项目类别:
财政年份:
2008
资助国家:
美国
项目状态:
已结题
起止时间:
2008-01-15 至 2012-12-31
关键词:
Autoimmune DiseasesBindingCD4 Positive T LymphocytesCD8B1 geneCarcinomaCell physiologyCellsCytokine GeneDNA BindingDNA-Binding ProteinsDiabetes MellitusExperimental ModelsFamilyFigs - dietaryGene ExpressionGene TargetingGenetic ProgrammingGenetic TranscriptionGraft RejectionHumanHuman ResourcesIL2 geneIL2RA geneIL4 geneImmuneImmune ToleranceInflammatoryInterferonsInterleukin-10Interleukin-2Jurkat CellsLaboratoriesMediatingModelingMolecularMusMutationNamesOrgan TransplantationParticipantPathologyPrincipal InvestigatorPublishingRegulationRegulatory T-LymphocyteReporterRepressionResearchResearch PersonnelRetroviral VectorStructureT-LymphocyteTechniquesThymus Glandallograft rejectiondesignexperiencegene inductionimprovedmembermutantnovel therapeuticsprogramspromoterresearch study
中文摘要
描述(由申请人提供):调节性T细胞对于器官移植排斥和自身免疫性疾病期间免疫介导的病理控制至关重要,因此了解这些细胞发挥功能的潜在机制对于促进人类免疫耐受至关重要。最近在实验模型中的研究已经确定,Foxp 3是DNA结合蛋白的叉头家族的成员,对于调节性T淋巴细胞谱系选择和功能的规范是必要且充分的。因此对获得性免疫耐受至关重要。Foxp 3的表达启动了一个独特的转录程序,包括GITR、CD 25、CTLA-4、IL-10和TGF 2等基因的诱导,以及IL-2和IFN?等促炎细胞因子基因的抑制。Foxp 3执行这种遗传程序的机制尚不清楚。本申请中提出的研究围绕Foxp 3如何与靶基因结合以及Foxp 3如何抑制或诱导这些基因座的转录的基本问题。拟议的研究将大大增加我们对Foxp 3如何调节基因表达的理解,从这些研究中获得的信息将与设计新的治疗策略相关,通过这些策略可以促进人类的耐受性。
英文摘要
DESCRIPTION (provided by applicant): Regulatory T cells are crucial for the control of immune-mediated pathology during organ transplant rejection and autoimmune disease, therefore understanding the underlying mechanisms by which these cells function will be critical for promoting immune tolerance in humans. Recent studies in experimental models have established that Foxp3, which is a member of the forkhead family of DNA binding proteins, is necessary and sufficient for specification of regulatory T lymphocyte lineage choice and function. and therefore is crucial for acquired immune tolerance. Expression of Foxp3 initiates a unique transcriptional program which includes the induction of genes such as GITR, CD25, CTLA-4, IL-10 and TGF2, and repression of pro-inflammatory cytokine genes such as IL-2 and IFN?. The mechanisms by which Foxp3 enforces this genetic program are unclear. The studies proposed in this application are centered around basic questions of how Foxp3 binds to target genes, and how Foxp3 represses or induces transcription at these loci. The proposed studies will add significantly to our understanding of how Foxp3 regulates gene expression, and the information gained from these studies will have relevance for the design of novel therapeutic strategies by which tolerance can be promoted in humans.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
HIPK1: a new immunomodulatory target for SLE
-
批准号:10647292
-
项目类别:
-
资助金额:$26.7万
-
财政年份:2023
-
负责人:ANDREW D WELLS
-
依托单位:
Intergenic cis regulatory elements in the control of IL-2 and IL-21
-
批准号:8656204
-
项目类别:
-
资助金额:$25.2万
-
财政年份:2013
-
负责人:ANDREW D WELLS
-
依托单位:
Intergenic cis regulatory elements in the control of IL-2 and IL-21
-
批准号:8776923
-
项目类别:
-
资助金额:$21.0万
-
财政年份:2013
-
负责人:ANDREW D WELLS
-
依托单位:
Regulation of Foxp3 Function
-
批准号:7875099
-
项目类别:
-
资助金额:$15.58万
-
财政年份:2009
-
负责人:ANDREW D WELLS
-
依托单位:
Regulation of Foxp3 Function
-
批准号:7555609
-
项目类别:
-
资助金额:$37.01万
-
财政年份:2008
-
负责人:ANDREW D WELLS
-
依托单位:
Regulation of Foxp3 Function
-
批准号:8206600
-
项目类别:
-
资助金额:$36.28万
-
财政年份:2008
-
负责人:ANDREW D WELLS
-
依托单位:
Regulation of Foxp3 Function
-
批准号:7371357
-
项目类别:
-
资助金额:$37.07万
-
财政年份:2008
-
负责人:ANDREW D WELLS
-
依托单位:
Regulation of Foxp3 Function
-
批准号:8009779
-
项目类别:
-
资助金额:$36.28万
-
财政年份:2008
-
负责人:ANDREW D WELLS
-
依托单位:
Role of Ikaros in IL-2 gene expression and T cell anergy
-
批准号:6874455
-
项目类别:
-
资助金额:$25.5万
-
财政年份:2004
-
负责人:ANDREW D WELLS
-
依托单位:
Role of Ikaros in IL-2 gene expression and T cell anergy
-
批准号:6780188
-
项目类别:
-
资助金额:$25.5万
-
财政年份:2004
-
负责人:ANDREW D WELLS
-
依托单位:
Cyclin-dependent kinases: Novel switches in anergy and targets for tolerance
-
批准号:8820987
-
项目类别:
-
资助金额:$29.31万
-
财政年份:2002
-
负责人:ANDREW D WELLS
-
依托单位:
Growth Factor Signaling, Cell Division and T cell Anergy
-
批准号:6601751
-
项目类别:
-
资助金额:$30.6万
-
财政年份:2002
-
负责人:ANDREW D WELLS
-
依托单位:
Growth Factor Signaling, Cell Division and T cell Anergy
-
批准号:6766804
-
项目类别:
-
资助金额:$34.0万
-
财政年份:2002
-
负责人:ANDREW D WELLS
-
依托单位:
Cyclin-dependent kinases: Novel switches in anergy and targets for tolerance
-
批准号:9173017
-
项目类别:
-
资助金额:$42.0万
-
财政年份:2002
-
负责人:ANDREW D WELLS
-
依托单位:
Cyclin-dependent kinases: Novel switches in anergy and targets for tolerance
-
批准号:7627193
-
项目类别:
-
资助金额:$41.13万
-
财政年份:2002
-
负责人:ANDREW D WELLS
-
依托单位:
Cyclin-dependent kinases: Novel switches in anergy and targets for tolerance
-
批准号:7860337
-
项目类别:
-
资助金额:$40.71万
-
财政年份:2002
-
负责人:ANDREW D WELLS
-
依托单位:
Cyclin-dependent kinases: Novel switches in anergy and targets for tolerance
-
批准号:8074559
-
项目类别:
-
资助金额:$40.31万
-
财政年份:2002
-
负责人:ANDREW D WELLS
-
依托单位:
Cyclin-dependent kinases: Novel switches in anergy and targets for tolerance
-
批准号:7525532
-
项目类别:
-
资助金额:$41.13万
-
财政年份:2002
-
负责人:ANDREW D WELLS
-
依托单位:
Cyclin-dependent kinases: Novel switches in anergy and targets for tolerance
-
批准号:8264559
-
项目类别:
-
资助金额:$40.31万
-
财政年份:2002
-
负责人:ANDREW D WELLS
-
依托单位:
Growth Factor Signaling, Cell Division and T cell Anergy
-
批准号:7054131
-
项目类别:
-
资助金额:$33.2万
-
财政年份:2002
-
负责人:ANDREW D WELLS
-
依托单位:
国内基金
海外基金
登录
查看更多内容
帽结合蛋白(cap binding protein)调控乙烯信号转导的分子机制
-
批准号:32170319
-
项目类别:面上项目
-
资助金额:58.00万元
-
批准年份:2021
-
负责人:董春海
-
依托单位:
帽结合蛋白(cap binding protein)调控乙烯信号转导的分子机制
-
批准号:--
-
项目类别:--
-
资助金额:58万元
-
批准年份:2021
-
负责人:董春海
-
依托单位:
ID1 (Inhibitor of DNA binding 1) 在口蹄疫病毒感染中作用机制的研究
-
批准号:31672538
-
项目类别:面上项目
-
资助金额:62.0万元
-
批准年份:2016
-
负责人:孙跃峰
-
依托单位:
番茄EIN3-binding F-box蛋白2超表达诱导单性结实和果实成熟异常的机制研究
-
批准号:31372080
-
项目类别:面上项目
-
资助金额:80.0万元
-
批准年份:2013
-
负责人:杨迎伍
-
依托单位:
P53 binding protein 1 调控乳腺癌进展转移及化疗敏感性的机制研究
-
批准号:81172529
-
项目类别:面上项目
-
资助金额:58.0万元
-
批准年份:2011
-
负责人:杨其峰
-
依托单位:
DBP(Vitamin D Binding Protein)在多发性硬化中的作用和相关机制的蛋白质组学研究
-
批准号:81070952
-
项目类别:面上项目
-
资助金额:35.0万元
-
批准年份:2010
-
负责人:刘师莲
-
依托单位:
研究EB1(End-Binding protein 1)的癌基因特性及作用机制
-
批准号:30672361
-
项目类别:面上项目
-
资助金额:24.0万元
-
批准年份:2006
-
负责人:徐宁志
-
依托单位: